Skip to content
COMPANY
PRODUCTS
R & D
Product Candidates Overview
Pipeline
Orphan Drug Designations
PARTNERING
INVESTOR RELATIONS
Press Releases
Events & Presentations
Stock Information
SEC Filings
XBRL Filings
Stockholder Meeting
Corporate Governance
Email Alerts
Investor Contact
BLOG
CONTACT
Press Releases
Oct 18, 2004
Hemispherx Biopharma Comments on Recent Release of Data on Primary Endpoint in Phase III Chronic Fatigue Syndrome Study
Oct 11, 2004
HEMISPHERX BIOPHARMA PRESENTS NEWPHASE III DATA ON AMPLIGEN® AT THE 7th INTERNATIONAL CONFERENCE FOR CHRONIC FATIGUE SYNDROME
Sep 27, 2004
Hemispherx Biopharma to Present New Data on Activity of Ampligen in Treating Chronic Fatigue Syndrome at Annual CFS Conference
Sep 09, 2004
Griffin Securities Initiates Research Coverage of Hemispherx Biopharma With Buy Rating
Sep 07, 2004
HEMISPHERX BIOPHARMA REPORTS COMMENCEMENT OF TREATMENT OF WNV
Aug 10, 2004
HEMISPHERX BIOPHARMA SECOND QUARTER 2004 EARNINGS ANNOUNCED
Aug 06, 2004
HEMISPHERX BIOPHARMA, INC. ANNOUNCES COMPLETION OF PRIVATE PLACEMENT
Aug 05, 2004
Hemispherx Biopharma To Announce Second Quarter Financial Results and to Update Clinical Activities on Wednesday, August 11th
Aug 02, 2004
HEMISPHERX BIOPHARMA TO REPORT NEW DATA ON PIVOTAL PHASE III STUDY IN CFS
Aug 02, 2004
HEMISPHERX BIOPHARMA ANNOUNCES PRIVATE PLACEMENT OF COMMON STOCK AND WARRANTS
58
59
60
61
62
63
64
65
66
67
68
<<
<
>
>>
Privacy